About Medicare’s Medication Therapy Management Program

What “Medication Therapy Management” Means in Medicare Part D

MTM is a set of services offered by Medicare Part D plans to help eligible members use their medications
safely and effectively. The goal is practical: improve therapeutic outcomes and reduce the risk of problems
like side effects, duplicate therapies, or harmful drug interactions. It’s not a new drug benefit, and it’s
not a “special program” you pay extra for. It’s a plan service designed to help people who take multiple
medications for multiple health conditionsexactly the scenario where small medication issues can snowball.

MTM can be especially helpful when your medication list has grown over time: a specialist adds something,
the primary care clinician changes a dose, the pharmacy suggests an OTC option, and suddenly your medicine
cabinet looks like it’s auditioning for a reality show.

Who Runs MTMand What It Costs You

It’s offered through your Medicare drug plan

MTM is tied to Medicare Part D (prescription drug coverage). Plans are required to have an MTM program that
targets certain beneficiaries and offers key services such as medication reviews. Depending on how your plan
is organized, MTM services may be delivered by the plan, a pharmacy network, or a contracted MTM provider.

MTM is typically no-cost for eligible members

If you qualify under your plan’s criteria (or if you’re in a related safety management program), you can
receive MTM services at no additional cost. In other words: this is one of those rare healthcare moments
where “free” doesn’t mean “suspicious.”

How You Qualify for Medicare MTM

Here’s the key point: your Part D plan identifies (“targets”) members for MTM based on Medicare rules and the
plan’s approved targeting criteria. Your doctor can encourage you to participate, but the plan determines
eligibility and enrollment for the MTM program.

The classic three-part targeting test

Many members qualify under a three-part framework: multiple chronic conditions, multiple Part D drugs, and a
predicted annual drug cost that meets or exceeds a threshold. Medicare sets maximum limits on how strict plans
are allowed to be when they define “multiple” in those categoriesso plans can’t make the bar ridiculously high
just to avoid doing the work.

• Multiple chronic diseases: Plans can require a minimum of 2 or 3 chronic conditions, but
  they cannot require more than 3.
• Multiple Part D drugs: Plans can require between 2 and 8 drugs, but cannot require more
  than 8.
• Annual cost threshold: Plans target members likely to have annual Part D drug costs at or
  above the MTM threshold amount (which can change by year).

The 10 “core chronic diseases” plans must include

Beginning in 2025, Medicare required Part D sponsors to include ten “core chronic diseases” in their targeting
criteria (plans may also include additional conditions). The ten core categories are:

• Alzheimer’s disease
• Bone disease-arthritis (including osteoporosis, osteoarthritis, and rheumatoid arthritis)
• Chronic congestive heart failure (CHF)
• Diabetes
• Dyslipidemia
• End-stage renal disease (ESRD)
• HIV/AIDS
• Hypertension
• Mental health conditions (including depression, schizophrenia, bipolar disorder, and chronic/disabling mental health conditions)
• Respiratory disease (including asthma, COPD, and chronic lung disorders)

If you’re in a drug management/safety program, MTM may apply too

Some members qualify for MTM because they are in a Part D drug management program (often related to opioid
safety rules). Medicare.gov notes that plans must offer MTM services to people who meet certain requirements
or are in a drug management program. Translation: even if you don’t meet the “multiple conditions +
multiple meds + cost threshold” route, safety-related enrollment can still trigger MTM support.

What You Actually Get With MTM

MTM isn’t a single phone call and a pat on the head. It usually includes two types of reviewsone big,
comprehensive review, plus ongoing targeted check-ins that focus on specific issues.

1) The Comprehensive Medication Review (CMR)

The CMR is the headline act: a real-time, interactive review and consultation with a pharmacist or other
qualified provider. It can be done in person or via telehealth. During a CMR, the reviewer looks at your
prescription meds and the real-life stuff people actually takeover-the-counter medications, herbals,
and supplementsbecause those can absolutely interact with prescriptions.

Plans must offer at least one CMR annually to targeted beneficiaries, and they must provide a written summary
afterward in a standardized format.

2) Targeted Medication Reviews (TMRs)

TMRs are smaller “zoom-in” reviews that look for specific medication therapy problemslike a newly risky drug
combination, a duplicate therapy, or a dose that may need adjustment. Think of TMRs as the program’s ongoing
“check engine” light scanner: not glamorous, but very good at preventing expensive surprises.

3) The written summary: the part you can actually use

Medicare describes the MTM written output in plain language: you may receive a written summary of your review,
a “Recommended To-Do List,” and a “Medication List.” In CMS documentation, the standardized written summary
after a CMR includes three components:

• CMR Cover Letter
• Medication Action Plan (MAP) your recommended actions and follow-ups
• Personal Medication List (PML) your updated med list to share with clinicians

One more important detail: CMS states the standardized format is not marketing material. So if your summary
reads like an ad, that’s a red flagand you should feel free to ask why your “Medication Action Plan” is
mysteriously pitching a timeshare.

What MTM Commonly Helps Catch

MTM is most valuable when it finds problems that are common, easy to miss, and fixable. Examples include:

• Drug-drug interactions: Two meds that are fine alone but risky together (especially when
  more meds get added over time).
• Therapeutic duplication: Two medications doing the same job (sometimes from different
  prescribers).
• Dosing issues: A dose that’s too high, too low, or needs adjustment for kidney function or
  age-related sensitivity.
• Side effects that look like “new symptoms”: Dizziness, constipation, sleep problems, or
  confusion that may actually be medication-related.
• Adherence obstacles: Complex schedules, cost barriers, or confusion about how/when to take
  a medication.
• OTC and supplement surprises: Common non-prescription products that can interfere with
  prescriptions (or worsen certain conditions).

The “win” is not just identifying the issueit’s translating it into a practical plan: what to ask your doctor,
what to monitor, and what to change (if your prescriber agrees).

A Walk-Through Example (With the Names Changed to Protect the Innocent)

Scenario: “Maria,” 72, has diabetes, hypertension, and CHF. She takes a diuretic, a blood
pressure medication, a diabetes medication, a statin, and a few “helpful” OTC products. She also sees two
specialists. Translation: her medication list has more guest stars than a season finale.

During a CMR, the MTM pharmacist notices Maria started an OTC anti-inflammatory for knee pain. Maria mentions
she’s been more swollen and short of breath lately. The pharmacist flags that the OTC medication may worsen
fluid retention and can be risky in heart failure. The pharmacist’s MAP recommends: stop the OTC unless her
clinician says otherwise, contact her prescriber about safer pain options, and monitor weight and swelling.

Nothing in that story is magical. It’s just a structured medication review that connects the dots across
conditions, prescriptions, and OTC productsexactly what MTM was designed to do.

What Changed Recently (And Why You Might Suddenly Qualify)

Medicare updated MTM eligibility rules starting in 2025, and those changes are meaningful because they can
expand who gets targeted for MTM services.

Core chronic diseases were codified and expanded

CMS codified the list of nine core chronic disease categories and added HIV/AIDS, making ten core categories
that plans must include in their targeting criteria (while still allowing plans to include additional diseases).

Plans must include Part D maintenance drugs in the “multiple drugs” calculation

Plans must include all Part D maintenance drugs when identifying beneficiaries taking multiple Part D drugs,
using information from a widely accepted drug database (and plans may choose to include all Part D drugs).

The MTM cost threshold methodology changedand the dollar amount can move each year

Beginning in 2025, the MTM cost threshold is based on the average annual cost of eight generic drugs (rather
than the prior approach that used a fixed threshold updated over time). CMS guidance states that the MTM cost
threshold for 2026 is $1,276, based on analysis of 2024 prescription drug event data. If your plan previously
told you “you don’t qualify,” the combination of these changes means it’s worth checking again.

CMRs must be real-time and interactive

CMS clarified that the comprehensive medication review must include a real-time interactive consultation,
whether done in person or via synchronous telehealth. In other words: MTM isn’t supposed to be a one-way
worksheet tossed over a fence. You get an actual conversation.

How to Get the Most Out of Your MTM Review

Before the review: do a “brown bag” inventory

Gather everything you take: prescriptions, OTC meds, vitamins, supplements, inhalers, creams, eye drops
everything. If you can’t bring the products, bring a list (and don’t rely on memory; memory is a fun liar).
Include:

• Medication name and strength
• How you actually take it (not how the label wishes you took it)
• What you take it for (if you know)
• Side effects you’ve noticed
• Any cost issues or skipped doses

During the review: say the quiet part out loud

The MTM clinician can only solve the problems you mention. If you stopped a medication because it made you
feel awful, say that. If you take half-doses to stretch an expensive prescription, say that too. The point is
safety and effectivenessnot a medication morality contest.

After the review: use the Medication Action Plan like a checklist

Your MAP is designed to turn a big conversation into manageable next steps. Pick one or two actions to do
firstlike calling your prescriber about a possible interaction, asking about a simpler dosing schedule, or
confirming whether an OTC product is safe with your conditions. Bring your Personal Medication List to every
healthcare visit (and especially to urgent care or the ER, where guessing is not a hobby we want).

Limitations: What MTM Is Not

MTM is powerful, but it has boundaries. It’s not a replacement for medical care, and it’s not a promise that
all medication problems will disappear forever.

• It doesn’t replace your prescriber. Pharmacists and MTM clinicians typically recommend
  changes, but your prescriber approves medication changes.
• It isn’t continuous care for everyone. MTM includes ongoing targeted reviews, but the depth
  and frequency vary by plan and by your risk factors.
• Not everyone will qualify. MTM is targeted. If your medication profile is simpler, your plan
  may not enroll youeven if you’d enjoy a helpful chat.

That said, you can still ask your pharmacist or clinician for a medication review outside the MTM program.
MTM is one route to medication supportnot the only one.

Frequently Asked Questions

Do I have to participate if my plan offers MTM?

Participation is generally voluntary. Plans offer MTM to targeted members, and you can usually accept or
decline. If you have questions about your specific situation, your plan’s member services can confirm whether
you were targeted and what services are available.

Can a caregiver join the CMR?

Many reviews can include an authorized representative or caregiver, especially if that person helps manage
medications day-to-day. If cognitive impairment is a concern, plans have guidance for conducting the review
with an authorized individual and documenting it appropriately.

Will MTM lower my drug costs?

Sometimes. MTM can identify opportunities like removing duplicate therapies, improving adherence (which can
reduce downstream medical costs), or asking prescribers about lower-cost alternatives when clinically
appropriate. But MTM can’t override your plan formulary, and it doesn’t guarantee a cheaper prescription.
Its primary job is safety and optimization.

Is MTM the same as “comprehensive medication management” (CMM)?

Not exactly. MTM in Part D has specific required elements (like an annual CMR and written summaries), while
comprehensive medication management is often described as a broader standard of care with ongoing follow-up
to ensure each medication is appropriate, effective, safe, and usable. MTM and CMM share a philosophy, but
they aren’t identical programs.

Conclusion

Medicare’s MTM program is one of the most underused “hidden helpers” in Part D: a structured way to make sure
your medications are doing their jobs without causing new problems. If you qualify, you can get a real-time
medication review, a written action plan, and a clean medication list you can share everywhere. If you don’t
qualify, you can still borrow the MTM mindset: keep an accurate list, ask questions, and treat OTC products
and supplements like real medications (because your body absolutely does).

Real-World Experiences With Medicare MTM (Added Stories & Takeaways)

Experience #1: The “I Didn’t Know That Was a Medication” Moment. A common theme in MTM calls is
that people don’t always consider OTC products and supplements “real” medications. One beneficiary described
the review as the first time anyone asked, in the same conversation, about allergy pills, sleep aids, vitamins,
and prescriptions. The MTM clinician didn’t scold or lecture; they simply mapped out what each product did,
when it was taken, and what could overlap. The beneficiary left with a shorter, clearer listand a new habit:
adding OTC items to the same medication list they bring to appointments. The practical takeaway: if it goes in
your mouth (or on your body) and changes how you feel, it belongs on your list.

Experience #2: The Caregiver “Translation” Benefit. Caregivers often say MTM helps because it
creates a shared language for follow-up. Instead of “Mom’s pills,” the caregiver ends up with a Personal
Medication List and a Medication Action Plan that spells out what to ask the doctor, what to monitor, and what
to confirm at the pharmacy. One caregiver explained that the MAP felt like a checklist they could actually
execute between appointments. The emotional bonus: less arguing about whether a medication is necessary and
more teamwork around what the prescriber recommends. The takeaway: MTM can reduce friction because it turns
“medication confusion” into “next steps.”

Experience #3: The “One Change, Big Difference” Story. MTM doesn’t always lead to dramatic
medication overhauls. Sometimes it’s one change: moving a dose to a different time of day to reduce dizziness,
clarifying “as needed” instructions, or catching a duplicate medication that snuck in during a transition of
care. A beneficiary who had multiple prescribers described MTM as a “second set of eyes” that helped connect
the dots across clinics. They didn’t feel pressured; they felt supported. The takeaway: MTM’s value often shows
up in small, specific fixes that make daily life smoother.

Experience #4: The Pharmacist PerspectiveStructure Beats Guesswork. Pharmacists who deliver MTM
often point out that the program’s structure matters: real-time conversation, a standardized written summary,
and a plan for follow-up. In busy healthcare settings, medication questions can get squeezed into the last two
minutes of a visit. MTM flips that script by creating a dedicated space for medication-focused problem solving.
The humor here is that the most “boring” partthe written summarycan be the most powerful, because it travels
with the patient to every appointment. The takeaway: when it comes to medications, documentation isn’t just
paperwork; it’s continuity.

Experience #5: The Confidence Boost. Several people describe MTM as the first time they felt
comfortable asking “basic” questions without feeling rushed: “Do I take this with food?” “What if I miss a
dose?” “Is it normal to feel tired?” Those questions are not basicthey’re how real people stay safe. The
takeaway: MTM can improve safety simply by making it easier to ask the questions that prevent mistakes.